Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ARRX for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where RITUXIMAB-ARRX was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for RITUXIMAB-ARRX

Side Effect Reports % Deaths Hosp.
Product storage error 165 47.6% 0 0
Circumstance or information capable of leading to medication error 116 33.4% 0 0
Off label use 56 16.1% 9 14
Intercepted product administration error 51 14.7% 0 0
Accidental exposure to product 17 4.9% 0 0
Intercepted product preparation error 16 4.6% 0 0
Fatigue 14 4.0% 6 8
Infusion related reaction 14 4.0% 6 7
Drug ineffective 12 3.5% 6 8
Dyspnoea 12 3.5% 4 6
Malaise 12 3.5% 4 5
Pruritus 12 3.5% 4 5
Drug intolerance 10 2.9% 6 8
Rash 10 2.9% 5 6
Rheumatoid arthritis 9 2.6% 6 8

Other Indications for RITUXIMAB-ARRX

Product used for unknown indication (247) Rheumatoid arthritis (15) Off label use (9) Non-hodgkin's lymphoma (8) Immune thrombocytopenia (7) Lymphoma (7) Multiple sclerosis (6)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

RITUXIMAB-ARRX Full Profile All Diffuse large b-cell lymphoma Drugs RITUXIMAB-ARRX Demographics RITUXIMAB-ARRX Timeline